Skip to main content
Premium Trial:

Request an Annual Quote

Compugen Agricultural Subsidiary Evogene to Close $2 Million Round

NEW YORK, Jan. 6-Evogene, the agricultural biotech subsidiary of Compugen, expects to close its first round of funding soon, Compugen said today.


The subsidiary expects the private placement to top out at about $2 million.


Evogene, which was officially launched in January 2002, uses Compugen technology to develop improved crops and plant strains that can produce valuable compounds.


For further information, see the company website.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.